Five Urban Legends of CNS Clinical Trial Methodology: Unsuccessful Solutions to the Problem of Failed Trials American College of Neuropsychopharmacology, 50th Annual Meeting, Waikoloa Beach, HI. (December 2011)   View

The Power of Expectation Bias American College of Neuropsychopharmacology, 50th Annual Meeting, Waikoloa Beach, HI. (December 2011) View

7 Deadly Sins: Proposed Guidelines for Reporting Clinical Trials Methodology Research American College of Neuropsychopharmacology, 50th Annual Meeting, Waikoloa Beach, HI. (December 2011) View

A 6-week Randomized, Double-blind, Placebo-controlled, Comparator Referenced, Multicenter Trial of Vabicaserin in Subjects with Acute Exacerbation of Schizophrenia American College of Neuropsychopharmacology, 50th Annual Meeting, Waikoloa Beach, HI. (December 2011) View

Some Urban Legends of CNS Clinical Trial Methodology: Unsuccessful Solutions to the Problem of Failed Trials The International Society for CNS Clinical Trials and Methodology, Amelia Island, FL (October, 2011).

7 Deadly Sins: Proposed Guidelines for Reporting Clinical Trials Methodology Research The International Society for CNS Clinical Trials and Methodology, Amelia Island, FL (October, 2011).

The Importance of Quality in Post-baseline Assessments in CNS Trials New Clinical Drug Evaluation Unit Annual Meeting, Boca Raton, FL (June 2011) . View

The Power of Expectation Bias The International Society for CNS Clinical Trials and Methodology, Washington, DC (February, 2011).

The Importance of Quality in Post Baseline Assessments in CNS Trials American College of Neuropsychopharmacology, 49th Annual Meeting, Miami Beach, FL. (December 2010)

The MARQ-AD: A New Measure of Interview Quality in Alzheimer's Disease Trials American College of Neuropsychopharmacology, 49th Annual Meeting, Miami Beach, FL. (December, 2010) View

The Relationship Between Interview Quality and Scoring Agreement: Evaluation of the Rater Applied Performance Scale American College of Neuropsychopharmacology, 49th Annual Meeting, Miami Beach FL. (December 2010) View

Assessing Interview Quality and Scoring Accuracy in Clinical Trials with CQC American College of Neuropsychopharmacology, 49th Annual Meeting, Miami Beach, FL. (December, 2010) View

The Importance of Quality in Post-baseline Assessments in CNS Trials The International Society for CNS Clinical Trials and Methodology, Autumn Conference, Baltimore, MD (October, 2010).

The Relationship Between Interview Quality and Scoring Agreement: Evaluation of the Rater Applied Performance Scale The International Society for CNS Clinical Trials and Methodology, Autumn Conference, Baltimore, MD (October, 2010).

The MARQ-AD: A New Measure of Interview Quality in Alzheimer's Disease Trials Alzheimer's Association International Conference on Alzheimer's Disease (ICAD), Honolulu, HI (July 2010).

Scale Rating Variability in Alzheimer's Disease Clinical Trials: A Literature Review Alzheimer's Association International Conference on Alzheimer's Disease (ICAD), Honolulu, HI (July 2010). View

Assessing Interview Quality and Scoring Accuracy in Clinical Trials with Continuous Quality Control (CQC) New Clinical Drug Evaluation Unit Annual Meeting, Boca Raton, FL (June 2010).

Remote Clinical Assessments: A Powerful Tool for Psychiatric Drug Trials World Psychiatric Association Regional Meeting, St. Petersburg, Russia (June 2010). View

Placebo Response Assessed by Site and Remote Blinded Centralized Raters in a GAD Trial New Clinical Drug Evaluation Unit Annual Meeting, Boca Raton, FL (June 2010). View

The Challenge of Subject Selection in Clinical Trials: New Data New Clinical Drug Evaluation Unit Annual Meeting, Boca Raton, FL (June 2010) . View

Assessing Interview Quality and Scoring Accuracy in Clinical Trials with Continuous Quality Control (CQC) The International Society for CNS Clinical Trials and Methodology, 6th Annual Scientific Meeting, Washington, DC (February, 2010).

Placebo Response Assessed by Site and Remote Blinded Centralized Raters in a GAD Trial The International Society for CNS Clinical Trials and Methodology, 6th Annual Scientific Meeting, Washington, DC (February, 2010).

The Challenge of Patient Ascertainment in Clinical Trials -- New Data International Society for CNS Clinical Trials and Methodology, Autumn Conference, San Diego, CA  (October 2009) . View

The MARQ-AD: A New Measure of Interview Quality in Alzheimer's Disease Trials The International Society for CNS Clinical Trials and Methodology, 6th Annual Scientific Meeting, Washington DC (February, 2010), Schizophrenia International Research Society Conference, Florence, Italy (April, 2010), New Clinical Drug Evaluation Unit Annual Meeting, Boca Raton, FL (June 2010).

Placebo Response Assessed by Site and Blinded Centralized Raters in a GAD Trial American College of Neuropsychopharmacology, Hollywood, FL (December 2009).

Same Versus Different Raters and Rater Quality in a Clinical Trial of Major Depressive Disorder: Impact on Placebo Response and Signal Detection International Society for CNS Clinical Trials and Methodology, Autumn Conference, San Diego, CA (October 2009). View

Trends in Placebo Response and Effect Size in Schizophrenia: A Meta-Analysis International Society for CNS Clinical Trials and Methodology, Autumn Conference, San Diego, CA (October 2009) . View

Assessment of depression diagnosis and severity: Comparability of telephone and in-person interview New Clinical Drug Evaluation Unit (June 2009), American Psychiatric Association (May 2009) View

Methods of Determining Inter-rater Reliability of the PANSS: a review of the literature American Psychological Associating (August 2009), International Congress on Schizophrenia Research (March 2009), International Society for CNS Clinical Trials and Methodology (October 2008). View

The Use of Videoconferencing with patients with Psychosis: A review of the Literature American Telemedicine Association (April 2009). View

The Use of Remote Centralized Raters via Live Two-Way Video in a Multicenter Clinical Trial for Schizophrenia American College of Neuropsychopharmacology, Scottsdale, AZ (December 2008). View

Sources of Unreliability in Depression Ratings American Psychological Association (August 2009), New Clinical Drug Evaluation Unit (June 2008). View

Site vs. Centralized Raters in a Clinical Depression Trial National Institute of Mental Health, New Clinical Drug Evaluation Unit, 46th Annual Meeting, Boca Raton, FL. (June, 2006). View

Face-to-face vs. Remote Assessment of Inter-rater Reliability on the HAMD National Institute of Mental Health, New Clinical Drug Evaluation Unit, 45th Annual Meeting, Boca Raton, FL. (June, 2005). View

Development and Reliability of a Combined Hamilton Depression, Anxiety, and Atypical Symptoms Scale American Psychiatric Association, 159th Annual Meeting, Toronto, CA. (May, 2006). View

Relationship Between Education, Years Experience, and Clinical Competence in Depression Rating Skills Drug Information Association, 42nd Annual Meeting, Philadelphia, PA. (2006, June). View

Impact of a Comprehensive HAMD Inter-Rater Reliability Training in a Multi-Site Trial National Institute of Mental Health, New Clinical Drug Evaluation Unit, 41st Annual Meeting, Phoenix, AZ (May, 2001). View

A Pilot Study of Video Telemedicine in the Assessment of Primary Care Patients with Anxiety and Depressive Disorders View

A comparison of face-to-face and remote administration of the Hamilton Depression Rating Scale via videoconferencing National Institute of Mental Health, New Clinical Drug Evaluation Unit, 44th Annual Meeting, Boca Raton, FL. (June, 2004) View